Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.

Ku BM, Kim SJ, Kim N, Hong D, Choi YB, Lee SH, Gong YD, Kim SY

Open source

DOI
10.1007/s00432-014-1623-5
Published
2014 May
Container
Journal of cancer research and clinical oncology
Publisher
Not recorded
Open access
yes

Credibility signals

supported Score 75/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00432-014-1623-5,
  title = {Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.},
  author = {Ku BM and Kim SJ and Kim N and Hong D and Choi YB and Lee SH and Gong YD and Kim SY},
  year = {2014},
  journal = {Journal of cancer research and clinical oncology},
  doi = {10.1007/s00432-014-1623-5},
  url = {https://doi.org/10.1007/s00432-014-1623-5}
}

RIS

TY  - JOUR
TI  - Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.
AU  - Ku BM
AU  - Kim SJ
AU  - Kim N
AU  - Hong D
AU  - Choi YB
AU  - Lee SH
AU  - Gong YD
AU  - Kim SY
PY  - 2014
JO  - Journal of cancer research and clinical oncology
DO  - 10.1007/s00432-014-1623-5
UR  - https://doi.org/10.1007/s00432-014-1623-5
ER  - 

APA

BM, K., SJ, K., N, K., D, H., YB, C., SH, L., YD, G., & SY, K. (2014). Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.. Journal of cancer research and clinical oncology. https://doi.org/10.1007/s00432-014-1623-5

Source records